Clinical Trial

AI-Based Prediction of Liver Metastasis in Colorectal Cancer (A Retrospective Study)

Recruiting
View on ClinicalTrials.gov →
Summary
This multicenter, retrospective study aims to develop and validate a multimodal deep learning model for predicting the risk of metachronous liver metastasis in patients with stage I-III colorectal cancer following curative resection. The model will integrate preoperative contrast-enhanced CT imaging, digitized histopathological whole-slide images, and standard clinical-pathological data. The primary objective is to assess the model's discriminatory performance, measured by the area under the receiver operating characteristic curve (AUC), and to compare its predictive accuracy against traditional prognostic factors such as TNM staging and serum carcinoembryonic antigen levels. This research utilizes existing archival data; no direct patient contact or intervention is involved. The ultimate goal is to provide a robust, data-driven tool for improved risk stratification, which could potentially guide personalized surveillance strategies and adjuvant therapy decisions in the future.
Trial Details
NCT Number NCT07399236
Lead Sponsor Tongji Hospital
Conditions Colorectal Cancer Liver Metastases (CRLM)
Enrollment 1,500 participants
Start Date 2015-01-01
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-10